Table of Content

Open Access iconOpen Access

RETRACTION

crossmark

Retraction: Safety and Efficacy of Biodegradable Patent Foramen Ovale Occluder in Patients with Migraine: A Clinical Trial

Xingbang Li1,#, Xuan Zheng2,#, Bowen Jin1, Yunyan Li1, Yongyu Shao1, Xiaoxian Deng1, Dingyang Li1, Shanshan Li1, Hongmei Zhou1, Jie Zhang3, Xianya Zhang4, Qunshan Shen1, Gangcheng Zhang2,*

1 Congenital Heart Disease Center, Wuhan Asia Heart Hospital, Wuhan University of Science and Technology, Wuhan, 430022, China
2 Structural Heart Disease Center, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China
3 Department of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
4 Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

Congenital Heart Disease 2023, 18(4), 489-489. https://doi.org/10.32604/chd.2023.031413

This article is a retraction of:

Safety and Efficacy of Biodegradable Patent Foramen Ovale Occluder in Patients with Migraine: A Clinical Trial
Read original article

Abstract

This article has no abstract.

Cite This Article

APA Style
Li, X., Zheng, X., Jin, B., Li, Y., Shao, Y. et al. (2023). Retraction: safety and efficacy of biodegradable patent foramen ovale occluder in patients with migraine: A clinical trial. Congenital Heart Disease, 18(4), 489-489. https://doi.org/10.32604/chd.2023.031413
Vancouver Style
Li X, Zheng X, Jin B, Li Y, Shao Y, Deng X, et al. Retraction: safety and efficacy of biodegradable patent foramen ovale occluder in patients with migraine: A clinical trial. Congeni Heart Dis. 2023;18(4):489-489 https://doi.org/10.32604/chd.2023.031413
IEEE Style
X. Li et al., "Retraction: Safety and Efficacy of Biodegradable Patent Foramen Ovale Occluder in Patients with Migraine: A Clinical Trial," Congeni. Heart Dis., vol. 18, no. 4, pp. 489-489. 2023. https://doi.org/10.32604/chd.2023.031413



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 537

    View

  • 253

    Download

  • 1

    Like

Share Link